For: | Fu XY, Tan DM, Liu CM, Gu B, Hu LH, Peng ZT, Chen B, Xie YL, Gong HY, Hu XX, Yao LH, Xu XP, Fu ZY, He LQ, Li SH, Long YZ, Li DH, Gu JL, Peng SF. Early hepatitis B viral DNA clearance predicts treatment response at week 96. World J Gastroenterol 2017; 23(16): 2978-2986 [PMID: 28522916 DOI: 10.3748/wjg.v23.i16.2978] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i16/2978.htm |
Number | Citing Articles |
1 |
Pu Zhou, Minhui Dong, Jinyu Wang, Fahong Li, Jiming Zhang, Jingwen Gu. Baseline serum miR‑125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg‑positive chronic hepatitis B. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6685
|
2 |
Hussam Murad, Haythum O Tayeb, Mahmoud Mosli, Misbahuddin Rafeeq, Mohammed Basheikh. Blood Levels of Glutamine and Nitrotyrosine in Patients with Chronic Viral Hepatitis. International Journal of General Medicine 2021; : 8753 doi: 10.2147/IJGM.S337909
|